Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zafgen Inc.
DescriptionSecond-generation methionine aminopeptidase 2 (MetAP2) inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat severe and complicated obesity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today